Name | Allina Health System |
---|---|
Organization Name | Allina Health System |
Location | 920 E 28th St, Minneapolis, Minnesota 55407 |
Type | Clinic Pharmacy |
Phone | (612) 775-3100 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
The "formulation" that disease prevention programs can reduce health care costs in the long term "is a pleasant fantasy," syndicated columnist Froma Harrop writes in the Providence Journal.
A team of researchers recently discussed the potential role of a new assay in bridging a major gap in SARS-CoV-2 research. This assay can throw light on 1) the selection of complementary monoclonal antibody candidates and 2) rapid identification of the immune escape to emerging RBD variants following vaccination or natural infection.
Changing the way that critically ill patients suffering from sepsis or multiple organ failure are fed could reduce liver dysfunction.
Just as summer is coming in and many are dusting off the barbecue a new study says barbecued food may not be that healthy.
› Verified 9 days ago
NPI Number | 1316901333 |
Organization Name | ALLINA HEALTH SYSTEM |
Doing Business As | ALLINA HEALTH HEART HOSPITAL PHARMACY |
Type | Clinic Pharmacy |
Address | 920 E 28th St, Minneapolis, MN 55407 |
Phone Number | 612-775-3100 |
News Archive
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
The "formulation" that disease prevention programs can reduce health care costs in the long term "is a pleasant fantasy," syndicated columnist Froma Harrop writes in the Providence Journal.
A team of researchers recently discussed the potential role of a new assay in bridging a major gap in SARS-CoV-2 research. This assay can throw light on 1) the selection of complementary monoclonal antibody candidates and 2) rapid identification of the immune escape to emerging RBD variants following vaccination or natural infection.
Changing the way that critically ill patients suffering from sepsis or multiple organ failure are fed could reduce liver dysfunction.
Just as summer is coming in and many are dusting off the barbecue a new study says barbecued food may not be that healthy.
› Verified 9 days ago
NPI Number | 1851174890 |
Organization Name | ALLINA HEALTH SYSTEM |
Type | Community/Retail Pharmacy |
Address | 920 E 28th St, Minneapolis, MN 55407 |
Phone Number | 612-775-3100 |
News Archive
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
The "formulation" that disease prevention programs can reduce health care costs in the long term "is a pleasant fantasy," syndicated columnist Froma Harrop writes in the Providence Journal.
A team of researchers recently discussed the potential role of a new assay in bridging a major gap in SARS-CoV-2 research. This assay can throw light on 1) the selection of complementary monoclonal antibody candidates and 2) rapid identification of the immune escape to emerging RBD variants following vaccination or natural infection.
Changing the way that critically ill patients suffering from sepsis or multiple organ failure are fed could reduce liver dysfunction.
Just as summer is coming in and many are dusting off the barbecue a new study says barbecued food may not be that healthy.
› Verified 9 days ago
News Archive
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
The "formulation" that disease prevention programs can reduce health care costs in the long term "is a pleasant fantasy," syndicated columnist Froma Harrop writes in the Providence Journal.
A team of researchers recently discussed the potential role of a new assay in bridging a major gap in SARS-CoV-2 research. This assay can throw light on 1) the selection of complementary monoclonal antibody candidates and 2) rapid identification of the immune escape to emerging RBD variants following vaccination or natural infection.
Changing the way that critically ill patients suffering from sepsis or multiple organ failure are fed could reduce liver dysfunction.
Just as summer is coming in and many are dusting off the barbecue a new study says barbecued food may not be that healthy.
› Verified 9 days ago
Mesa Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2603 Bloomington Ave, Minneapolis, Minnesota 55407 Phone: (612) 501-5009 | |
Alina Health System Type: Community/Retail Pharmacy Location: 913 E 28th Street, Minneapolis, Minnesota 55407 Phone: (612) 863-5370 | |
Allina Health System Type: Clinic Pharmacy Location: 920 E 28th St, Minneapolis, Minnesota 55407 Phone: (612) 775-3100 | |
Cvs Pharmacy #07172 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2001 Nicollet Ave, Minneapolis, Minnesota 55404 Phone: (612) 872-2656 | |
Cvs Pharmacy #05996 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3655 Central Ave Ne, Minneapolis, Minnesota 55418 Phone: (612) 789-2460 |